Genentech

Roche will leverage PicnicHealth's real-world datasets for Alzheimer’s Disease, Alzheimer’s Disease-related dementia and myasthenia gravis.

Brian Pelkowski, Genentech's global head of oncology strategy for personalized healthcare, discusses why connecting data points is essential for improving the patient journey and ensuring patients receive continuous care.

The original focus will be on multiple sclerosis but will extend to include Huntington's disease and hemophilia. 

Dubbed Clover Therapeutics, the unit's first project will be a partnership with Genentech targeting ocular diseases among senior populations.